Pharmaceutical -80℃ freeze storage single-use bag
MDI AseptiBag LT is designed for cold chain applications in biopharmaceuticals. It supports low-temperature storage down to -80°C and is suitable for multiple freeze-thaw cycles involving high-value pharmaceutical raw materials and process intermediates. Additionally, it is made of low-extractable ULDPE film, which provides excellent durability to maintain integrity even in sub-zero environments during freezing, storage, transportation, and thawing processes. 【Benefits of Implementation】 - Supports low-temperature storage down to -80°C, maintaining the cold chain - Protects the quality of high-value pharmaceutical raw materials and process intermediates - Offers durability to maintain integrity even in sub-zero environments
Inquire About This Product
basic information
【Features】 - Supports low-temperature storage down to -80℃ - Utilizes low-extraction ULDPE film - Compatible with various tests including extracts and insoluble particles - Bag capacities range widely from 3mL to 50L - Sterilized with gamma rays (up to 50kGy) 【Our Strengths】 As a trading company that meets the needs of customers in pharmaceutical development and manufacturing, we continue to pursue contributions to society while considering the environment and safety. By weaving the "invisible threads" between people and goods, and between people and people, we deliver valuable products that contribute to our customers' new value creation.
Price range
Delivery Time
Applications/Examples of results
- Vaccine raw materials - Antibody drugs - Recombinant proteins - Cell culture media
catalog（1）
Download All Catalogs
Company information
Starting as an import trading company in 1927, we have been developing our business with many overseas suppliers and domestic customers over the years. Through our services of connecting the two together, Higuchi has become the well trusted "Japan distribution channel" for suppliers, and the "dependable vendor" who provides a stable supply of the latest high-valued overseas products to customers. Today, we conduct not only importing but also exporting businesses, trilateral trades, and overseas business investments as well. We have also expanded to local subsidiaries in the United States and China, to which we are able to effectively network overseas. Higuchi believes in the criticalness of providing a stable supply to customers, and we also place the highest priority on the coexistence with suppliers, to whom we can mutually develop together in a long-term perspective. Your support and consideration to our corporate philosophy would be much appreciated.
![[Data] Biopharmaceutical Process Raw Material Handbook 2025](https://image.mono.ipros.com/public/product/image/13657/IPROS13840560265736924842.png?w=280&h=280)